# India IoT in Healthcare Market Size, Share & Forecast, By Product Type, Care Setting & Application, 2026-2031 --- ## Market Overview # CHAPTER 1 - Market Overview The India IoT in Healthcare Market connects medical devices, patients, clinicians and health information systems through sensors, communication networks and analytics platforms. Demand is underpinned by more than **73 crore ABHA accounts as of January 2025**, which expand the addressable population for consent-based digital records, connected diagnostics and longitudinal patient monitoring. South India represents the leading adoption cluster because Bengaluru, Hyderabad and Chennai combine tertiary hospitals, medical-device manufacturing, cloud engineering and health-technology start-ups. South India accounted for approximately **34% of national medical-device demand in 2025**, creating a concentrated installation base for connected monitors, diagnostic equipment and hospital IoT platforms. Regulatory access is shaped by the Medical Devices Rules, 2017, CDSCO software guidance, the Digital Personal Data Protection Act, 2023 and the Digital Personal Data Protection Rules, 2025. Connected products making medical claims require risk classification, software validation and licensing, while health-data processing requires consent, security controls and accountable data-fiduciary practices. India remains dependent on imported sensors, monitoring components and high-end connected medical equipment. Medical devices historically recorded import dependence above **70%**, although production incentives had commissioned **22 greenfield projects covering 55 products by September 2025**. Localization can improve margins, service responsiveness and cybersecurity control for IoT healthcare suppliers. ## KPIs at a Glance * Market Value: USD 2,348 million (2025) * Dominant Region: South India (2025) * Dominant Segment: Wearable Medical Devices (fastest growing, 2026-2031) * Total Number of Players: 115 ## Future Outlook The India IoT in Healthcare Market is projected to expand from USD 2,348 million in 2025 to USD 6,211 million by 2031. Historical growth of 15.80% between 2020 and 2025 reflected telemedicine normalization, hospital digitization and wider availability of connected sensors. Forecast growth of 17.60% will be supported by remote patient monitoring, home-based chronic care, cellular IoT and integration with ABDM-compliant records. The installed connected-care endpoint base is expected to rise from 51.2 million in 2025 to 183.0 million by 2031 as device prices decline and subscription-based software revenue increases. Value creation will progressively shift from standalone hardware toward monitoring subscriptions, interoperable platforms, predictive analytics and managed cybersecurity. Hospitals will remain the largest procurement channel, but home healthcare is expected to deliver the strongest incremental demand as providers extend care beyond discharge. Local manufacturing will reduce procurement lead times, while cloud and edge architectures will enable multi-site monitoring. Investors should prioritize vendors with clinically validated devices, recurring software revenue, ABDM integration and hospital partnerships. Suppliers unable to demonstrate data security, measurable clinical outcomes and compatibility with existing hospital information systems will face longer procurement cycles and higher customer-acquisition costs. --- | | | | --- | --- | | **17.60%** Forecast CAGR | **$6,211 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2026-2031** | Historical CAGR **15.80%** | --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** India * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2026-2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Care Setting, End User, Disease Area, Channel, Technology, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Product Type + Wearable Medical Devices - Vital-sign wearables - Connected glucose monitors - Cardiac monitoring patches + Stationary Medical Devices - Connected bedside monitors - Smart diagnostic equipment - Connected critical-care devices + Implanted Medical Devices - Connected cardiac implants - Smart drug-delivery implants - Implantable neurostimulators + Healthcare IoT Platforms - Device-management platforms - Clinical data integration platforms - Remote monitoring dashboards * Care Setting + Hospitals and Clinics - Intensive-care environments - General wards - Outpatient departments + Home Healthcare - Post-discharge monitoring - Chronic-care monitoring - Elderly home care + Diagnostic and Ambulatory Centers - Diagnostic laboratories - Imaging centers - Day-care surgery centers + Long-Term and Elder Care - Assisted-living facilities - Nursing facilities - Palliative-care centers * End User + Healthcare Providers - Hospital networks - Independent clinics - Diagnostic chains + Patients and Caregivers - Chronic-disease patients - Elderly patients - Family caregivers + Payers and Insurers - Private health insurers - Public health schemes - Employer health programs + Pharmaceutical and Clinical Research Organizations - Pharmaceutical manufacturers - Contract research organizations - Decentralized trial operators * Disease Area + Cardiovascular and Diabetes - Arrhythmia monitoring - Blood-pressure management - Continuous glucose monitoring + Respiratory and Sleep - COPD monitoring - Connected respiratory therapy - Sleep-apnea monitoring + Neurology and Elder Care - Fall detection - Dementia monitoring - Neurological rehabilitation + Oncology and Post-Acute Care - Treatment toxicity monitoring - Post-operative monitoring - Recovery pathway management * Channel + Direct Enterprise Sales - Hospital account sales - Enterprise framework contracts - Managed-service contracts + Medical Device Distributors - National distributors - Regional distributors - Specialty clinical distributors + Digital Health Platforms - Telehealth platforms - Home-care platforms - Digital pharmacy ecosystems + Public Procurement and Tenders - Central procurement agencies - State health tenders - Public hospital procurement * Technology + Wi-Fi and Bluetooth Low Energy - Bluetooth medical sensors - Hospital Wi-Fi devices - Wearable gateway connectivity + Cellular IoT and 5G - LTE-M connectivity - Narrowband IoT - Private 5G healthcare networks + Cloud and Edge Computing - Clinical cloud platforms - Edge gateways - Hybrid hospital infrastructure + AI-Enabled Analytics and Interoperability - Predictive deterioration analytics - Clinical decision support - ABDM-compatible interoperability * Geography + South India - Karnataka - Tamil Nadu - Telangana and Andhra Pradesh + West India - Maharashtra - Gujarat - Goa + North India - Delhi NCR - Uttar Pradesh - Punjab and Haryana + East and Central India - West Bengal - Odisha - Madhya Pradesh and Chhattisgarh --- ## Market Trajectory # India IoT in Healthcare Market Size, Share & Forecast, By Product Type, Care Setting & Application, 2026-2031 ## India IoT in Healthcare Market **Geography:** India | **Historical Period:** 2020-2025 | **Forecast Period:** 2026-2031 The India IoT in Healthcare Market reached **USD 2,348 million in 2025**, supported by connected patient monitoring, medical wearables, hospital automation and cloud-based device management. More than **73 crore ABHA accounts were created by January 2025**, establishing a national identity and interoperability layer for connected-care workflows. ### Report Metadata Summary | Base Year | Historical CAGR | Historical Period | Forecast Period | Forecast CAGR | | --- | --- | --- | --- | --- | | 2025 | 15.80% | 2020-2025 | 2026-2031 | 17.60% | # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. ### Historical and Projected Market Size | Year | Market Size (USD Mn) | Period | | --- | --- | --- | | 2020 | 1,128 | Historical | | 2021 | 1,288 | Historical | | 2022 | 1,498 | Historical | | 2023 | 1,748 | Historical | | 2024 | 2,000 | Historical | | 2025 | 2,348 | Base Year | | 2026F | 2,734 | Forecast | | 2027F | 3,198 | Forecast | | 2028F | 3,751 | Forecast | | 2029F | 4,413 | Forecast | | 2030F | 5,220 | Forecast | | 2031F | 6,211 | Forecast | ### YoY Growth Rate | Year | YoY Growth (%) | Growth Context | | --- | --- | --- | | 2021 | 14.2% | Telemedicine and connected monitoring scale-up | | 2022 | 16.3% | Hospital digital investment recovery | | 2023 | 16.7% | Wearable and remote-care expansion | | 2024 | 14.4% | Procurement normalization | | 2025 | 17.4% | ABDM integration and home-care adoption | | 2026F | 16.4% | Security and compliance investment | | 2027F | 17.0% | Cellular IoT device deployment | | 2028F | 17.3% | Insurer-supported monitoring programs | | 2029F | 17.6% | AI-enabled clinical workflow expansion | | 2030F | 18.3% | Home-based acute and chronic care scale | | 2031F | 19.0% | Platform and recurring-service monetization | ### Market Value vs Volume Growth | Year | Value Growth (%) | Connected Endpoint Growth (%) | Revenue per Endpoint Growth (%) | | --- | --- | --- | --- | | 2020 | - | - | - | | 2021 | 14.2% | 18.6% | -3.7% | | 2022 | 16.3% | 23.3% | -5.7% | | 2023 | 16.7% | 24.0% | -5.9% | | 2024 | 14.4% | 22.3% | -6.4% | | 2025 | 17.4% | 22.8% | -4.4% | | 2026 | 16.4% | 21.7% | -4.3% | | 2027 | 17.0% | 22.3% | -4.4% | | 2028 | 17.3% | 23.1% | -4.7% | | 2029 | 17.6% | 24.0% | -5.1% | | 2030 | 18.3% | 25.1% | -5.5% | ### Historical Market Performance (2020-2025) The market added USD 1,220 million between 2020 and 2025. The strongest historical annual expansion occurred in 2025 at 17.4%, while 2021 recorded the lowest growth at 14.2%. Connected endpoints expanded faster than market value because falling sensor costs increased adoption among smaller hospitals, diagnostic centers and home-care operators. The installed endpoint base increased from 18.8 million in 2020 to 51.2 million in 2025. Growth shifted after 2022 from emergency telehealth deployments toward recurring chronic-care monitoring, connected diagnostics and hospital command-center implementations. ### Forecast Market Outlook (2026-2031) Forecast growth accelerates toward 19.0% in 2031 as software, analytics and managed monitoring contribute a larger revenue share. The endpoint base is projected to reach 183.0 million by 2031, while annual revenue allocated per endpoint declines to USD 33.9 because of hardware commoditization. Platform subscriptions, cybersecurity and clinical analytics will offset device price compression. Home healthcare and post-discharge monitoring are expected to expand faster than hospital procurement, while public digital infrastructure will reduce integration costs for vendors supporting ABHA-linked records and consent-driven data exchange. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The India IoT in Healthcare Market is transitioning from hardware-led procurement toward connected-care ecosystems combining devices, software, cloud infrastructure and clinical services. This trajectory increases the strategic importance of recurring revenue, interoperability and cybersecurity for investors and healthcare operators. | Year | Market Size (USD Mn) | YoY Growth (%) | Connected Care Endpoints (Mn) | Hospital IoT Penetration (%) | Annual Revenue per Endpoint (USD) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 1,128 | - | 18.8 | 12% | 60.0 | Historical | | 2021 | 1,288 | 14.2% | 22.3 | 14% | 57.8 | Historical | | 2022 | 1,498 | 16.3% | 27.5 | 17% | 54.5 | Historical | | 2023 | 1,748 | 16.7% | 34.1 | 21% | 51.3 | Historical | | 2024 | 2,000 | 14.4% | 41.7 | 25% | 48.0 | Historical | | 2025 | 2,348 | 17.4% | 51.2 | 30% | 45.9 | Base Year | | 2026 | 2,734 | 16.4% | 62.3 | 36% | 43.9 | Forecast and Latest Operating KPIs | | 2027 | 3,198 | 17.0% | 76.2 | 43% | 42.0 | Forecast and Industry Outlook | | 2028 | 3,751 | 17.3% | 93.8 | 51% | 40.0 | Forecast and Industry Outlook | | 2029 | 4,413 | 17.6% | 116.3 | 59% | 37.9 | Forecast and Industry Outlook | | 2030 | 5,220 | 18.3% | 145.5 | 68% | 35.9 | Forecast and Industry Outlook | | 2031 | 6,211 | 19.0% | 183.0 | 77% | 33.9 | Forecast and Industry Outlook | **KPI 1, Connected Care Endpoints:** **51.2 million endpoints, 2025, India**. Scale improves platform economics and creates demand for device lifecycle management. India recorded more than 1.02 billion internet subscribers by December 2025, supporting cloud-connected care delivery. **KPI 2, Hospital IoT Penetration:** **30%, 2025, India**. Penetration remains concentrated in large private hospitals, leaving mid-sized facilities under-addressed. More than 1.86 lakh primary-care centers were operational by June 2026, creating a substantial public-sector connectivity opportunity. **KPI 3, Annual Revenue per Endpoint:** **USD 45.9, 2025, India**. Device commoditization reduces hardware revenue per unit, increasing the importance of software subscriptions and analytics. Medical devices remained 70-80% import-dependent, reinforcing localization and service-margin opportunities. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Product Type | **Fastest Growing Segment:** Care Setting | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Product Type | Wearable Medical Devices; Stationary Medical Devices; Implanted Medical Devices; Healthcare IoT Platforms | | 2 | Care Setting | Hospitals and Clinics; Home Healthcare; Diagnostic and Ambulatory Centers; Long-Term and Elder Care | | 3 | End User | Healthcare Providers; Patients and Caregivers; Payers and Insurers; Pharmaceutical and Clinical Research Organizations | | 4 | Disease Area | Cardiovascular and Diabetes; Respiratory and Sleep; Neurology and Elder Care; Oncology and Post-Acute Care | | 5 | Channel | Direct Enterprise Sales; Medical Device Distributors; Digital Health Platforms; Public Procurement and Tenders | | 6 | Technology | Wi-Fi and Bluetooth Low Energy; Cellular IoT and 5G; Cloud and Edge Computing; AI-Enabled Analytics and Interoperability | | 7 | Geography | South India; West India; North India; East and Central India | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Product Type** - Product Type remains the dominant dimension because connected hardware represents the initial procurement trigger for hospitals and patients. Wearable Medical Devices lead adoption through glucose, cardiac and vital-sign monitoring, while Healthcare IoT Platforms capture higher recurring margins by aggregating data, managing devices and supporting clinical decision-making across multiple care locations. **Care Setting** - Care Setting is the fastest-growing dimension as monitoring moves from hospitals to homes, ambulatory centers and long-term care facilities. Home Healthcare is the strongest Level-2 growth pool because providers seek lower-cost post-discharge pathways, insurers require measurable outcomes and patients increasingly accept app-connected devices for continuous chronic-disease management. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis India ranked third among selected Asia-Pacific peer markets by 2025 IoT healthcare revenue, behind China and Japan but ahead of South Korea and Indonesia. Its lower care cost, large chronic-disease population, national digital-health infrastructure and billion-plus internet subscriber base support above-average expansion. ### KPI Summary * Focus Country Ranking: **3rd** * Focus Country Market Size: **USD 2,348 Mn** * India CAGR (2026-2031): **17.60%** | Country | Market Size | CAGR (%) | Internet Subscribers (Mn) | Health Expenditure Per Capita (USD) | | --- | --- | --- | --- | --- | | India | USD 2,348 Mn | 17.60% | 1,029 | 100 | | China | USD 7,900 Mn | 16.20% | 1,100 | 741 | | Japan | USD 4,100 Mn | 13.40% | 118 | 4,734 | | South Korea | USD 1,900 Mn | 15.10% | 52 | 3,659 | | Indonesia | USD 930 Mn | 18.80% | 224 | 155 | ### Market Position India holds third position with USD 2,348 million in 2025, supported by more than 73 crore ABHA accounts and a rapidly expanding connected-care infrastructure. ### Growth Advantage India's 17.60% forecast CAGR exceeds Japan's 13.40% and South Korea's 15.10%, reflecting lower device penetration, faster hospital digitization and expanding home-care demand. ### Competitive Strengths India combines 1.03 billion internet subscribers, 1.86 lakh primary-care centers and national health-data infrastructure, creating a scalable deployment environment for affordable connected-care solutions. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the India IoT in Healthcare Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Expansion of National Digital Health Infrastructure ABDM created more than **73 crore ABHA accounts (January 2025, India)**, reducing identity and record-exchange friction for connected-care providers. * More than **5 lakh health professionals (January 2025, India)** were registered within the digital-health ecosystem, increasing the clinician base able to participate in interoperable monitoring workflows. * ABDM reported **45.37 crore linked health records (December 2024, India)**, creating longitudinal data that can improve remote triage, risk scoring and adherence management. * The Digital Health Incentive Scheme continued supporting verified ABHA-linked records in **2026**, improving the economic case for hospitals to digitize patient interactions. ### Scaling Telemedicine and Distributed Care India delivered more than **47 crore telemedicine consultations (June 2026, India)**, normalizing remote clinical interactions that can incorporate IoT data. * More than **2.34 lakh healthcare providers (June 2026, India)** were onboarded on the national telemedicine platform, creating a broad distribution network for connected monitoring. * AI-supported clinical decision systems assisted **28.2 crore consultations (April 2023-November 2025, India)**, demonstrating the ability to combine connected data with decision support at scale. * More than **1.86 lakh primary-care centers (June 2026, India)** increase the number of community locations capable of hosting connected diagnostics and specialist teleconsultations. ### Connectivity and Chronic-Disease Management India reached **1,028.61 million internet subscribers (December 2025, India)**, supporting cloud-connected monitoring across hospitals and homes. * Broadband subscribers exceeded **1,007 million (December 2025, India)**, improving the reliability of video consultation, device synchronization and high-frequency health-data transmission. * India's 2025 GDP reached approximately **USD 3.96 trillion (2025, India)**, supporting hospital capital expenditure and household spending on preventive devices. * Out-of-pocket expenditure remained **43.89% of current health spending (2023, India)**, strengthening demand for monitoring models that reduce avoidable admissions and travel costs. --- ## Market Challenges ### Cybersecurity and Patient Data Exposure Connected medical devices expand attack surfaces while CERT-In requires reportable cyber incidents within **6 hours (2022 directions, India)**. * The Digital Personal Data Protection Rules became operational in **2025**, increasing compliance requirements for consent notices, safeguards, breach handling and data processing. * CERT-In identifies medical reports and personal identifiers as common breach targets, increasing the financial and reputational cost of weak device authentication. **Healthcare is a named target sector (2021, India)**. * Hospital buyers increasingly require encryption, audit logs and patching commitments, adding **multi-year support obligations (2025 procurement cycle, India)** that smaller vendors may struggle to finance. ### Fragmented Systems and Interoperability Costs India's health ecosystem includes more than **3.49 lakh registered facilities (December 2024, India)**, many operating heterogeneous information systems and device protocols. * ABDM was designed to address fragmented data capture and non-standardized systems, confirming that interoperability remains a structural constraint across **pan-India healthcare networks**. * Legacy bedside devices frequently lack modern APIs, forcing hospitals to deploy gateways and middleware that can add **10-20% to implementation budgets (2025 industry benchmark, India)**. * Clinical integration requires validation across hospital information systems, electronic medical records and monitoring platforms, extending enterprise deployment cycles to approximately **6-18 months (2025, large hospitals)**. ### Import Dependence and Affordability Pressure India continued to import approximately **70-80% of medical devices (2025, India)**, exposing connected-care suppliers to currency, freight and component risks. * High-end device import dependence exceeded **85% when the PLI program was initiated in 2020**, indicating persistent gaps in sensors, semiconductors and precision components. * Out-of-pocket payments accounted for **43.89% of current health expenditure (2023, India)**, limiting consumer willingness to pay for premium monitoring subscriptions without insurer support. * Public tenders prioritize affordability and local value addition, creating pricing pressure for suppliers while increasing working-capital requirements across **state-level procurement cycles (2025, India)**. --- ## Market Opportunities ### Remote Patient Monitoring as a Subscription Service Home healthcare is expanding at approximately **20% annually (2025, India)**, creating recurring revenue opportunities for monitoring subscriptions and clinical services. * Vendors can combine devices, dashboards and nurse-led escalation under per-patient monthly contracts, shifting revenue from one-time hardware toward **12-36 month subscriptions (2026-2031, India)**. * Hospital groups, insurers and home-care operators benefit through lower readmission risk and improved capacity utilization, with home treatment potentially reducing daily care costs by **up to 75% in selected cases (2025, India)**. * Opportunity realization requires insurer reimbursement, clinically validated alerts and integration with discharge protocols across **large hospital networks and urban home-care programs**. ### Localized Connected Medical Device Manufacturing The medical-device PLI program commissioned **22 greenfield projects covering 55 products (September 2025, India)**, improving the foundation for local IoT hardware. * Local production can reduce import, service and inventory costs while increasing gross-margin control for connected monitors, gateways and wearable devices across a **USD 15.2 billion medical-device market (2025, India)**. * Manufacturers, electronics suppliers and contract development partners benefit from demand for sensor integration, firmware, enclosures and testing services as localization moves beyond final assembly. * Scaling requires domestic semiconductor access, certified testing infrastructure and software-validation capability under the **Medical Devices Rules, 2017**. ### AI-Enabled Connected Diagnostics AI-supported screening identified an additional **12-16% of potential TB cases (2023-2025, India)**, demonstrating monetizable value from connected diagnostics. * Analytics vendors can monetize per-test, per-facility and platform-license models by combining medical sensors with automated triage and reporting across public screening programs. * Hospitals, diagnostic chains and governments benefit through higher screening throughput, earlier intervention and reduced dependency on specialists at every point of care. * Commercial scale requires representative clinical datasets, explainable algorithms and software regulatory approvals, particularly when algorithms influence diagnosis or treatment decisions. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The market is moderately fragmented, combining multinational device manufacturers, hospital-technology vendors and Indian remote-monitoring start-ups. Entry barriers include clinical validation, regulatory licensing, interoperability, enterprise sales cycles and post-deployment support. * **Key players:** 10 * **New Entrants (last 5 yrs):** 27 ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Philips India | - | Amsterdam, Netherlands | 1891 | Connected patient monitoring, tele-ICU and ambulatory monitoring | | Wipro GE Healthcare | - | Bengaluru, India | 1990 | Connected imaging, patient monitoring and hospital digital systems | | Siemens Healthineers India | - | Erlangen, Germany | 2017 | Digital health platforms, connected diagnostics and clinical collaboration | | Medtronic India | - | Dublin, Ireland | 1949 | Connected cardiac, diabetes and implanted medical devices | | Abbott India | - | Abbott Park, United States | 1888 | Continuous glucose monitoring and connected cardiovascular devices | | Omron Healthcare India | - | Kyoto, Japan | 1933 | Connected blood-pressure, respiratory and home-monitoring devices | | Nihon Kohden India | - | Tokyo, Japan | 1951 | Networked patient monitoring, neurology and critical-care systems | | Dozee | - | Bengaluru, India | 2015 | Contactless remote patient monitoring and hospital command centers | | Tricog Health | - | Bengaluru, India | 2014 | Connected ECG diagnostics and remote cardiac-care networks | | Janitri Innovations | - | Bengaluru, India | 2016 | Connected maternal and fetal monitoring solutions | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Connected Device Installed Base * Platform Interoperability Coverage * Recurring Revenue Growth * Service Gross Margin ### Analysis Covered * **Market Share Analysis:** Assesses vendor position across devices, platforms and care settings. * **Cross Comparison Matrix:** Benchmarks operational reach, interoperability, revenue growth and service margins. * **SWOT Analysis:** Evaluates product strength, clinical evidence, scalability and execution risks. * **Pricing Strategy Analysis:** Compares hardware, subscription, managed-service and per-patient commercial models. * **Company Profiles:** Reviews portfolios, target customers, partnerships and India market positioning. --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, recurring revenue, margins, clinical validation, exit potential * **Corporates:** procurement cost, interoperability, cybersecurity, uptime, care outcomes * **Government:** access, compliance, localization, data governance, health resilience * **Operators:** device utilization, alerts, workflow integration, retention, service quality * **Financial institutions:** project finance, subscription stability, covenants, credit risk ### What You'll Gain * Market sizing and trajectory * Policy and compliance mapping * Connected-care demand indicators * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Reviewed ABDM adoption and registry data * Mapped connected medical-device regulatory classifications * Analyzed hospital digitization and connectivity indicators * Reviewed company portfolios and deployment evidence #### Primary Research * Hospital chief information officers interviewed * Biomedical engineering directors interviewed * Remote-care program managers interviewed * Medical-device product leaders interviewed #### Validation and Triangulation * Validated findings across 324 respondents * Cross-checked device and platform revenues * Reconciled hospital and home-care demand * Tested forecast assumptions across scenarios ### Phase 2: Market Size Estimation #### Top-Down Assessment * India medical-device and digital-health expenditure pools * Allocation across hospitals, homes and diagnostics * ABDM, TRAI and health-infrastructure indicators #### Bottom-Up Modeling * Connected-device installed base by vendor * Hardware, subscription and service pricing benchmarks * Endpoint volume multiplied by annual revenue #### Forecasting and Scenario Analysis * Connectivity, hospital capex and chronic-care variables * Localization, reimbursement and cybersecurity adoption scenarios * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the India IoT in Healthcare Market value chain from connected-device development and platform integration to provider deployment and home-based care. * Connected Medical Device Manufacturers * IoT Platforms and System Integrators * Hospitals and Diagnostic Networks * Home Healthcare and Payer Programs #### Sample Size A total of 324 respondents were engaged across market segments to ensure robust coverage of connected-device supply, technology deployment and healthcare demand. * Connected Medical Device Manufacturers - 78 respondents (Product Director, Regulatory Affairs Manager) * IoT Platforms and System Integrators - 74 respondents (Solutions Architect, Healthcare Practice Head) * Hospitals and Diagnostic Networks - 96 respondents (Chief Information Officer, Biomedical Engineering Director) * Home Healthcare and Payer Programs - 76 respondents (Remote Care Manager, Health Insurance Product Head) #### Validation and Triangulation Validation compared evidence across respondent cohorts, device categories, technology platforms, healthcare providers and payer-supported care programs. * Cross-checked adoption rates across care settings * Reconciled device shipments with platform subscriptions * Compared operational and strategic respondent estimates * Validated endpoint economics against provider budgets --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: What was the size of the India IoT in Healthcare Market in 2025? **A:** The India IoT in Healthcare Market was valued at USD 2,348 million in 2025. Revenue included connected medical devices, remote patient monitoring systems, healthcare IoT platforms, device connectivity, analytics and associated support services. Wearable Medical Devices represented the largest product pool, while Hospitals and Clinics remained the leading care setting. Market scale was reinforced by more than 73 crore ABHA accounts, widespread broadband access and sustained digital investment by private hospital networks. **Data used:** USD 2,348 million market value in 2025; 73 crore ABHA accounts in January 2025. **So what:** Suppliers should prioritize clinically validated products that integrate with national health-data infrastructure and hospital workflows. #### Q: How fast will the India IoT in Healthcare Market grow through 2031? **A:** The market is forecast to reach USD 6,211 million by 2031, representing a 17.60% CAGR between 2026 and 2031. Growth will accelerate as connected monitoring expands into home healthcare, long-term care and post-discharge pathways. The connected endpoint base is projected to increase from 51.2 million in 2025 to 183.0 million in 2031. Software subscriptions, AI-enabled analytics and managed monitoring will contribute a rising share of incremental revenue. **Data used:** USD 6,211 million forecast value in 2031; 17.60% forecast CAGR. **So what:** Investors should favor vendors capable of converting device installations into recurring platform and service revenue. #### Q: Where will the market's profit pool shift during the forecast period? **A:** Profit pools will move from standalone hardware toward recurring software, remote clinical services, cybersecurity and analytics. Device volumes are projected to expand faster than market value, reducing annual revenue per endpoint from USD 45.9 in 2025 to USD 33.9 in 2031. Vendors can protect margins through subscription pricing, managed device services and workflow integration. Platforms capable of aggregating multiple manufacturers' devices will capture stronger customer retention and higher lifetime value than single-product vendors. **Data used:** USD 45.9 annual revenue per endpoint in 2025; USD 33.9 in 2031. **So what:** Hardware companies need software and service capabilities to avoid margin compression as device prices decline. #### Q: What is the largest constraint on adoption? **A:** Interoperability and cybersecurity represent the most material constraints. Hospitals operate heterogeneous devices, information systems and network environments, making integration costly and time-consuming. Connected devices also process sensitive clinical information and must satisfy medical-device, privacy and cyber-incident requirements. Suppliers without secure update mechanisms, reliable APIs and local technical support face longer qualification cycles. Import dependence further increases component and maintenance costs, particularly for specialized sensors and high-end monitoring systems. **Data used:** 3.49 lakh registered health facilities in December 2024; 70-80% medical-device import dependence. **So what:** Procurement strategies should evaluate lifecycle security, interoperability and support costs rather than hardware price alone. #### Q: How does India compare with other Asia-Pacific IoT healthcare markets? **A:** India ranked third among the selected peer markets in 2025, behind China and Japan but ahead of South Korea and Indonesia. India's per-capita health spending remains lower than mature markets, but its forecast growth exceeds Japan and South Korea because penetration is earlier, chronic-care demand is substantial and national digital infrastructure reduces onboarding friction. Indonesia may grow faster from a smaller base, while China retains the largest absolute revenue pool. **Data used:** India market size of USD 2,348 million in 2025; India forecast CAGR of 17.60%. **So what:** India offers a favorable combination of scale and growth but requires affordable product architecture and localized execution. #### Q: Which demand driver has the greatest impact on connected-care adoption? **A:** The strongest structural driver is the shift from episodic hospital treatment toward continuous monitoring of chronic and post-acute patients. More than 47 crore telemedicine consultations demonstrate broad acceptance of remote clinical interaction, while 1.03 billion internet subscribers provide the connectivity layer. Hospitals use IoT to manage capacity, detect deterioration and extend care beyond discharge. Patients adopt connected devices when monitoring lowers travel, hospitalization and consultation costs. **Data used:** More than 47 crore telemedicine consultations by June 2026; 1,028.61 million internet subscribers in December 2025. **So what:** Vendors should align offerings with defined care pathways and measurable reductions in utilization rather than consumer wellness alone. #### Q: Which market segments offer the strongest investment potential? **A:** Home Healthcare, AI-Enabled Analytics and Interoperability, and connected cardiovascular and diabetes monitoring provide the strongest investment potential. These segments combine large patient populations, frequent data generation and recurring engagement. Wearable devices provide distribution scale, while enterprise platforms increase switching costs. The most defensible companies will pair clinically validated hardware with proprietary algorithms, hospital integration and recurring monitoring revenue. Public-sector screening and decentralized clinical research represent additional specialized growth pools. **Data used:** Home healthcare identified as the fastest-growing care setting for 2026-2031; Wearable Medical Devices held 38% of 2025 product revenue. **So what:** Capital should target integrated platforms with evidence of clinical outcomes, retention and repeatable deployment economics. --- ## Table of Contents # CHAPTER 14 - Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases, Market Assessment, Go-To-Market Strategy, and Survey, delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. India IoT in Healthcare Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 India IoT in Healthcare Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. India IoT in Healthcare Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Expansion of National Digital Health Infrastructure ##### 3.1.2 Scaling Telemedicine and Distributed Care ##### 3.1.3 Connectivity and Chronic-Disease Management ##### 3.1.4 Interoperable Health Data Infrastructure #### 3.2 Market Challenges ##### 3.2.1 Cybersecurity and Patient Data Exposure ##### 3.2.2 Fragmented Systems and Interoperability Costs ##### 3.2.3 Import Dependence and Affordability Pressure ##### 3.2.4 Clinical Validation and Procurement Complexity #### 3.3 Market Opportunities ##### 3.3.1 Remote Patient Monitoring as a Subscription Service ##### 3.3.2 Localized Connected Medical Device Manufacturing ##### 3.3.3 AI-Enabled Connected Diagnostics ##### 3.3.4 Insurer-Supported Chronic-Care Programs #### 3.4 Market Trends ##### 3.4.1 Shift Toward Home-Based Monitoring ##### 3.4.2 Edge Analytics for Real-Time Alerts ##### 3.4.3 Platform-Based Device Management ##### 3.4.4 Outcome-Linked Subscription Pricing #### 3.5 Government Regulation ##### 3.5.1 Medical Devices Rules Compliance ##### 3.5.2 Digital Personal Data Protection ##### 3.5.3 ABDM Health Data Management ##### 3.5.4 CERT-In Cyber Incident Reporting ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. India IoT in Healthcare Market Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. India IoT in Healthcare Market Segmentation #### 8.1 Product Type ##### 8.1.1 Wearable Medical Devices ##### 8.1.2 Stationary Medical Devices ##### 8.1.3 Implanted Medical Devices ##### 8.1.4 Healthcare IoT Platforms #### 8.2 Care Setting ##### 8.2.1 Hospitals and Clinics ##### 8.2.2 Home Healthcare ##### 8.2.3 Diagnostic and Ambulatory Centers ##### 8.2.4 Long-Term and Elder Care #### 8.3 End User ##### 8.3.1 Healthcare Providers ##### 8.3.2 Patients and Caregivers ##### 8.3.3 Payers and Insurers ##### 8.3.4 Pharmaceutical and Clinical Research Organizations #### 8.4 Disease Area ##### 8.4.1 Cardiovascular and Diabetes ##### 8.4.2 Respiratory and Sleep ##### 8.4.3 Neurology and Elder Care ##### 8.4.4 Oncology and Post-Acute Care #### 8.5 Channel ##### 8.5.1 Direct Enterprise Sales ##### 8.5.2 Medical Device Distributors ##### 8.5.3 Digital Health Platforms ##### 8.5.4 Public Procurement and Tenders #### 8.6 Technology ##### 8.6.1 Wi-Fi and Bluetooth Low Energy ##### 8.6.2 Cellular IoT and 5G ##### 8.6.3 Cloud and Edge Computing ##### 8.6.4 AI-Enabled Analytics and Interoperability #### 8.7 Geography ##### 8.7.1 South India ##### 8.7.2 West India ##### 8.7.3 North India ##### 8.7.4 East and Central India ### 9. India IoT in Healthcare Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Connected Device Installed Base ##### 9.2.4 Platform Interoperability Coverage ##### 9.2.5 Recurring Revenue Growth ##### 9.2.6 Service Gross Margin #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Philips India ##### 9.5.2 Wipro GE Healthcare ##### 9.5.3 Siemens Healthineers India ##### 9.5.4 Medtronic India ##### 9.5.5 Abbott India ##### 9.5.6 Omron Healthcare India ##### 9.5.7 Nihon Kohden India ##### 9.5.8 Dozee ##### 9.5.9 Tricog Health ##### 9.5.10 Janitri Innovations ### 10. India IoT in Healthcare Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Hospital Capital Procurement ##### 10.1.2 Subscription-Based Monitoring Procurement ##### 10.1.3 Public Tender Qualification ##### 10.1.4 Home-Care Device Selection #### 10.2 Corporate Spend Patterns ##### 10.2.1 Device Acquisition Budgets ##### 10.2.2 Platform Subscription Budgets ##### 10.2.3 Integration and Cybersecurity Spending ##### 10.2.4 Maintenance and Support Spending #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Hospital Interoperability Constraints ##### 10.3.2 Clinician Alert Fatigue ##### 10.3.3 Patient Adherence Barriers ##### 10.3.4 Insurer Outcome Verification #### 10.4 User Readiness for Adoption ##### 10.4.1 Digital Maturity of Hospitals ##### 10.4.2 Patient Connectivity Readiness ##### 10.4.3 Clinician Workflow Acceptance ##### 10.4.4 Payer Reimbursement Readiness #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Readmission Reduction ##### 10.5.2 Bed Capacity Optimization ##### 10.5.3 Preventive Intervention ##### 10.5.4 Multi-Disease Monitoring Expansion ### 11. India IoT in Healthcare Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Tier 2 Hospital Monitoring Whitespace #### 1.2 Home Chronic-Care Subscription Models #### 1.3 Public-Sector Connected Diagnostics #### 1.4 Device-Agnostic Platform Opportunity ### 2. Marketing and Positioning Recommendations #### 2.1 Clinical Outcome Positioning #### 2.2 Total Cost of Ownership Messaging #### 2.3 Data Security Differentiation #### 2.4 ABDM Interoperability Positioning ### 3. Distribution Plan #### 3.1 Direct Hospital Enterprise Sales #### 3.2 Regional Medical Device Distributors #### 3.3 Home Healthcare Partnerships #### 3.4 Public Procurement Channels ### 4. Channel and Pricing Gaps #### 4.1 Affordable Mid-Tier Device Packages #### 4.2 Per-Patient Subscription Pricing #### 4.3 Managed Monitoring Service Gaps #### 4.4 Rural Connectivity Pricing ### 5. Unmet Demand and Latent Needs #### 5.1 Post-Discharge Monitoring #### 5.2 Rural Specialist Access #### 5.3 Elderly Fall Detection #### 5.4 Multi-Morbidity Monitoring ### 6. Customer Relationship #### 6.1 Clinical Implementation Support #### 6.2 Device Lifecycle Management #### 6.3 Patient Engagement Programs #### 6.4 Outcome Reporting ### 7. Value Proposition #### 7.1 Earlier Clinical Intervention #### 7.2 Lower Avoidable Hospitalization #### 7.3 Improved Asset Utilization #### 7.4 Secure Longitudinal Data ### 8. Key Activities #### 8.1 Device Regulatory Approval #### 8.2 Hospital System Integration #### 8.3 Clinical Evidence Generation #### 8.4 Cybersecurity Operations ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Select Priority Care Pathways ##### 9.1.2 Establish Clinical Reference Sites ##### 9.1.3 Build Local Support Capacity ##### 9.1.4 Scale Through Hospital Networks #### 9.2 Export Entry Strategy ##### 9.2.1 Align International Device Standards ##### 9.2.2 Target Comparable Emerging Markets ##### 9.2.3 Build Regional Distribution Partnerships ##### 9.2.4 Establish Cross-Border Data Controls ### 10. Entry Mode Assessment #### 10.1 Direct Subsidiary #### 10.2 Joint Venture #### 10.3 Distribution Partnership #### 10.4 Technology Licensing ### 11. Capital and Timeline Estimation #### 11.1 Regulatory and Product Localization #### 11.2 Commercial Team Build-Out #### 11.3 Clinical Pilot Investment #### 11.4 Working Capital Requirements ### 12. Control vs Risk Trade-Off #### 12.1 Product Control #### 12.2 Data Governance Control #### 12.3 Channel Dependency #### 12.4 Regulatory Liability ### 13. Profitability Outlook #### 13.1 Hardware Gross Margin #### 13.2 Software Recurring Margin #### 13.3 Service Delivery Economics #### 13.4 Customer Lifetime Value ### 14. Potential Partner List #### 14.1 Hospital Networks #### 14.2 Telecom Operators #### 14.3 Home Healthcare Providers #### 14.4 Health Insurers ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Regulatory Submission and Approval ##### 15.2.2 Clinical Pilot Completion ##### 15.2.3 Commercial Partnership Activation ##### 15.2.4 Multi-City Deployment Scale-Up ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage - Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1 - Large Enterprise End Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2 - Mid-Size Enterprise End Users ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3 - Small and Emerging Enterprise End Users ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4 - Institutional and Government End Users ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 GDP and Healthcare Expenditure Linkages ##### 4.1.2 Digital Infrastructure Expansion Impact ##### 4.1.3 Hospital Capital Investment Cycles ##### 4.1.4 Import Dependency on Connected Devices #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Device Use ##### 4.2.2 Chronic and Post-Acute Monitoring Patterns ##### 4.2.3 Brand Loyalty vs Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against Manual Monitoring ##### 4.3.3 Regional Pricing Disparities ##### 4.3.4 Total Cost of Ownership Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Medical Device Certification Requirements ##### 4.4.2 Cybersecurity and Privacy Awareness ##### 4.4.3 Perception of Domestic vs Imported Devices ##### 4.4.4 After-Sales Service Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Regional Hospital Clusters and Demand Hotspots ##### 4.5.2 Caregiver Influence on Monitoring Adoption ##### 4.5.3 Clinician Influence and Referral Behavior ##### 4.5.4 Digital Adoption and E-Procurement Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Impact of Medical Conferences and Demonstrations ##### 4.6.2 Role of Digital Clinical Education ##### 4.6.3 Distributor Influence on Hospital Purchases ##### 4.6.4 System Integrator Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Gaps Between Current Devices and Clinical Workflows #### 5.2 Latent Demand in Tier 2 and Tier 3 Cities #### 5.3 Willingness to Adopt Subscription Monitoring #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us